1 in 11 people over age 65 diagnosed with a healthcare-associated C. difficile infection die within one month.
Clostridioides difficile infection (CDI)
General Information
Clostridioides difficile (C. difficile) is an anaerobic bacterium, widely distributed in soil and the intestinal tracts of animals.
Currently, no vaccine is licensed for the prevention of CDI.
Transmission
The transmission of C. difficile can be patient-to-patient, via contaminated hands of healthcare workers or by environmental contamination.
Symptoms
Clostridioides difficile (C. difficile) is an anaerobic bacterium, widely distributed in soil and the intestinal tracts of animals. The clinical spectrum of C. difficile infection (CDI) ranges from mild diarrhoea to severe life-threatening pseudomembranous colitis.
Epidemiology
The number of deaths occurring as the direct consequence of healthcare-associated CDI can be estimated at 3,700 per year in the EU/EEA.
The burden of healthcare-associated CDIs in acute care hospitals in the EU/EEA was estimated at 123,997 cases annually.
Members area
